Alexion Pharmaceuticals, Switzerland

The company in Switzerland


Alexion Pharmaceuticals is an exporter from Switzerland,the company sell DO 0199-12BOG; PEDIDO 5-2634; DECLARACION 1 DE 1; FACTURA(S) 90121927; (24 VIALES) SOLIRIS and related products to Switzerland market.

The comany exports goods from Switzerland and lading goods at ,the products and country of origin is Switzerland.

Contact Information

Company Name: Alexion Pharmaceuticals
Business Type: trading,export,wholesale
Main Products: DO 0199-12BOG; PEDIDO 5-2634; DECLARACION 1 DE 1; FACTURA(S) 90121927; (24 VIALES) SOLIRIS
Telephone: Search Phone Number
Email: Search Email Address
Port Of Lading:
Address and More: AVENUE DU TRIBUNAL FEDERAL 34, 1005, LAUSANNE, Switzerland
Country: Switzerland

The Related Information Of Alexion Pharmaceuticals On Internet
  • Leadership | Raptor Pharmaceuticals | Rare Disease
    Raptor Pharmaceuticals is developing therapeutics that treat rare and often fatal diseases like cystic fibrosis, cystinosis, and Huntington's disease.
  • Actavis - Wikipedia
    Actavis Generics (formerly known as Watson Pharmaceuticals and Actavis, plc, prior to the acquisition of Allergan, inc) is a global pharmaceutical company focused on ...
  • Alcon - Wikipedia
    Alcon is an American global medical company specializing in eye care products and headquartered in Hünenberg, Switzerland. Alcon's American headquarters are located ...
  • Alexion Completes Acquisition of Synageva | Alexion ...
    CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (Nasdaq:ALXN) announced today that it has successfully completed its previously announced acquisition ...
  • Alexion Pharmaceuticals, Inc
    Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with severe and life-threatening rare ...
  • Annual Reports to Shareholders - Alexion Pharmaceuticals
    Alexion Pharmaceuticals 2015 Annual Report. What We See. Add to Briefcase. Alexion Pharmaceuticals 2014 Annual Report. Breakthrough Medical Innovation for Severe and ...
Related Companies